Cargando…
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors
Virus-based tumour vaccines offer many advantages compared to other antigen-delivering systems. They generate concerted innate and adaptive immune response, and robust CD8(+) T cell responses. We engineered a non-replicating pseudotyped influenza virus (S-FLU) to deliver the well-known cancer testis...
Autores principales: | Kandasamy, Matheswaran, Gileadi, Uzi, Rijal, Pramila, Tan, Tiong Kit, Lee, Lian N, Chen, Jili, Prota, Gennaro, Klenerman, Paul, Townsend, Alain, Cerundolo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831609/ https://www.ncbi.nlm.nih.gov/pubmed/36626205 http://dx.doi.org/10.7554/eLife.76414 |
Ejemplares similares
-
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1(157-165) tumor-specific peptide
por: Shenderov, Eugene, et al.
Publicado: (2021) -
Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein
por: Xiao, Julie Huiyuan, et al.
Publicado: (2018) -
A Dominant Role for the Immunoproteasome in CD8(+) T Cell Responses to Murine Cytomegalovirus
por: Hutchinson, Sarah, et al.
Publicado: (2011) -
Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells
por: Bedard, Melissa, et al.
Publicado: (2019) -
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Bentley, Emma M., et al.
Publicado: (2021)